Tubular carcinoma, treatable and slow-growing, has a good prognosis and often needs less aggressive treatment.

Among patients with renal cell carcinoma, those with larger tumors may yield the most benefit from SBRT compared with other ...

While both are called medullary carcinoma, these cancers differ in many ways: ...

Thymic epithelial tumors are a rare group of malignancies originating in the thymus gland, that includes thymoma and thymic ...

Compared with other ablative therapies, stereotactic body radiotherapy might offer a ‘particularly advantageous option’ for ...

Medically reviewed by Renita White, MD Cancer that develops in the ovaries (the egg-producing reproductive organs) is ...

A new review article published in Genes & Diseases sheds light on the complex molecular mechanisms through which ...

Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.

Dr. Alan Tan explores circulating tumor DNA, its role in clinical trials and its potential impact on patients with renal cell ...

A research team led by Prof. SUN Cheng from the University of Science and Technology of China (USTC) of the Chinese Academy of Sciences, along with collaborators from the Agency for Science, ...